Your browser doesn't support javascript.
loading
Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care.
Marquina, Clara; Talic, Stella; Zomer, Ella; Vargas-Torres, Sandra; Petrova, Marjana; Wolfe, Rory; Abushanab, Dina; Lybrand, Sean; Thomson, David; Stratton, Giles; Ofori-Asenso, Richard; Liew, Danny; Ademi, Zanfina.
Affiliation
  • Marquina C; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia (Marquina, Talic, Zomer, Vargas-Torres, Petrova, Wolfe, Abushanab, Ofori-Asenso, Liew, and Ademi); Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australi
  • Talic S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia (Marquina, Talic, Zomer, Vargas-Torres, Petrova, Wolfe, Abushanab, Ofori-Asenso, Liew, and Ademi).
  • Zomer E; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia (Marquina, Talic, Zomer, Vargas-Torres, Petrova, Wolfe, Abushanab, Ofori-Asenso, Liew, and Ademi).
  • Vargas-Torres S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia (Marquina, Talic, Zomer, Vargas-Torres, Petrova, Wolfe, Abushanab, Ofori-Asenso, Liew, and Ademi).
  • Petrova M; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia (Marquina, Talic, Zomer, Vargas-Torres, Petrova, Wolfe, Abushanab, Ofori-Asenso, Liew, and Ademi).
  • Wolfe R; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia (Marquina, Talic, Zomer, Vargas-Torres, Petrova, Wolfe, Abushanab, Ofori-Asenso, Liew, and Ademi).
  • Abushanab D; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia (Marquina, Talic, Zomer, Vargas-Torres, Petrova, Wolfe, Abushanab, Ofori-Asenso, Liew, and Ademi); Pharmacy Department, Hamad Medical Corporation, Doha, Qatar (Abushanab).
  • Lybrand S; Amgen Europe GmbH (Lybrand).
  • Thomson D; Amgen Australia Pty Ltd, Australia (Thomson).
  • Stratton G; IQVIA Australia, Australia (Stratton).
  • Ofori-Asenso R; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia (Marquina, Talic, Zomer, Vargas-Torres, Petrova, Wolfe, Abushanab, Ofori-Asenso, Liew, and Ademi).
  • Liew D; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia (Marquina, Talic, Zomer, Vargas-Torres, Petrova, Wolfe, Abushanab, Ofori-Asenso, Liew, and Ademi).
  • Ademi Z; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia (Marquina, Talic, Zomer, Vargas-Torres, Petrova, Wolfe, Abushanab, Ofori-Asenso, Liew, and Ademi); Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australi
J Clin Lipidol ; 16(4): 498-507, 2022.
Article in En | MEDLINE | ID: mdl-35606299

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Cholesterol, LDL Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: J Clin Lipidol Journal subject: BIOQUIMICA / METABOLISMO Year: 2022 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Cholesterol, LDL Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: J Clin Lipidol Journal subject: BIOQUIMICA / METABOLISMO Year: 2022 Document type: Article Country of publication: Estados Unidos